OpenBilldrug price receipt

NADAC week of 2026-10-14

BANZEL 40 MG/ML SUSPENSION

FDA nonproprietary name: rufinamide

For 460 mL

Pharmacies pay

$1,678.41 filed

460 × $3.64872 per ML

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$1,935.17 estimated

$1,678.41 + $251.76 (15%) + $5.00 fee per fill = $1,935.17

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

BANZEL 40 MG/ML SUSPENSION is how the CMS NADAC file names this product. The FDA NDC Directory lists it as rufinamide, under the trade name “Banzel”.

FDA gives its dosage form as suspension and its route as oral.

The labeler, the company named on the label, is Eisai Inc.

FDA lists no Established Pharmacologic Class for it.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 62856-0584-46.

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $1,678.41 for 460 mL (460 × $3.64872 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.

NADAC also lists, on the row of one brand NDC, what pharmacies pay for the generic equivalent, a different product: $0.20341 per ML filed.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

The NDC

Other strengths, forms and brands

5 other products in the NADAC file share the FDA nonproprietary name rufinamide with BANZEL 40 MG/ML SUSPENSION.

ProductPharmacies pay per unitMedicare per unit
BANZEL 40 MG/ML SUSPENSION this page
brand · suspension
$3.64872 per ML filed
eff. 2026-09-23
We don’t know yet
BANZEL 200 MG TABLET
brand · tablet, film coated
$12.61034 per EA filed
eff. 2026-09-23
We don’t know yet
BANZEL 400 MG TABLET
brand · tablet, film coated
$25.18264 per EA filed
eff. 2026-09-23
We don’t know yet
RUFINAMIDE 40 MG/ML SUSPENSION
generic · suspension
$0.20341 per ML filed
eff. 2026-09-23
We don’t know yet
RUFINAMIDE 200 MG TABLET
generic · tablet, film coated / tablet
$0.881 per EA filed
eff. 2026-09-23
We don’t know yet
RUFINAMIDE 400 MG TABLET
generic · tablet, film coated / tablet
$1.39131 per EA filed
eff. 2026-09-23
We don’t know yet

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why does this page start at 460 mL?
NADAC prices this product per ML. The FDA NDC Directory’s package description gives 460 mL in one package for this product’s NDC (“1 BOTTLE in 1 CARTON (62856-584-46) / 460 mL in 1 BOTTLE”), so the card starts at one package: 460 ML. Change it to match your prescription.